1![DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATE DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATE](https://www.pdfsearch.io/img/e6dad8e4912a09f2f36cdb7a2b3010e0.jpg) | Add to Reading ListSource URL: bch.nus.edu.sgLanguage: English - Date: 2015-08-20 23:15:40
|
---|
2![Abstract Conjugation of anticancer drugs to biocompatible water soluble polymers is an attractive approach to improve the drug’s blood solubility and stability, tumour targeting properties and antitumour efficiency, w Abstract Conjugation of anticancer drugs to biocompatible water soluble polymers is an attractive approach to improve the drug’s blood solubility and stability, tumour targeting properties and antitumour efficiency, w](https://www.pdfsearch.io/img/dfe98b34bd7eef7187f36e653773683b.jpg) | Add to Reading ListSource URL: dspace.fsktm.um.edu.myLanguage: English - Date: 2009-12-31 01:50:07
|
---|
3![2005 Bowden, S, R. McCaw, P. A. White, J. N. Crofts and C. K. Aitken[removed]Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. Journal of Viral Hepatitis. 12:[removed]Bull, R. A., G. 2005 Bowden, S, R. McCaw, P. A. White, J. N. Crofts and C. K. Aitken[removed]Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. Journal of Viral Hepatitis. 12:[removed]Bull, R. A., G.](https://www.pdfsearch.io/img/37337e6311d7dad3e1e8288e17870f54.jpg) | Add to Reading ListSource URL: ach2.publishpath.comLanguage: English - Date: 2012-09-03 01:18:09
|
---|
4![Chapter 10 Final Discussion, Future Perspective and Conclusion 10.1 Final discussion To investigate the outcome of applying the polymer drug conjugation strategy to Chapter 10 Final Discussion, Future Perspective and Conclusion 10.1 Final discussion To investigate the outcome of applying the polymer drug conjugation strategy to](https://www.pdfsearch.io/img/e80b0449197cd534050dd84b6a7942f9.jpg) | Add to Reading ListSource URL: dspace.fsktm.um.edu.myLanguage: English - Date: 2009-12-31 01:50:07
|
---|
5![Microsoft Word[removed]Peripheral Neuropathy amend bp.doc Microsoft Word[removed]Peripheral Neuropathy amend bp.doc](https://www.pdfsearch.io/img/68349d7657b7753b3e34b2b25386bb4d.jpg) | Add to Reading ListSource URL: www.rma.gov.auLanguage: English - Date: 2014-05-06 01:28:00
|
---|
6![Microsoft Word[removed]Peripheral Neuropathy amend rh.doc Microsoft Word[removed]Peripheral Neuropathy amend rh.doc](https://www.pdfsearch.io/img/2ce1159a9a337790af2ef04bd5c6c76f.jpg) | Add to Reading ListSource URL: www.rma.gov.auLanguage: English - Date: 2014-05-06 01:27:59
|
---|
7![ZERIT® (stavudine) ZERIT® (stavudine) Capsules ZERIT® (stavudine) for Oral Solution (Patient Information Leaflet Included) WARNING ZERIT® (stavudine) ZERIT® (stavudine) Capsules ZERIT® (stavudine) for Oral Solution (Patient Information Leaflet Included) WARNING](https://www.pdfsearch.io/img/65d16821067da2d87e83dd0f55e5d5d3.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:08:07
|
---|
8![HIGHLIGHTS OF PRESCRIBING INFORMATION ----------------------DOSAGE FORMS AND STRENGTHS--------------------• Tablet: 600-mg tablets supplied in 30-count bottles[removed]These highlights do not include all the informati HIGHLIGHTS OF PRESCRIBING INFORMATION ----------------------DOSAGE FORMS AND STRENGTHS--------------------• Tablet: 600-mg tablets supplied in 30-count bottles[removed]These highlights do not include all the informati](https://www.pdfsearch.io/img/a8b33facecd687aedbe2b0a4e579024d.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:51:21
|
---|
9![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BARACLUDE safely and effectively. See full prescribing information for BARACLUDE. ® HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BARACLUDE safely and effectively. See full prescribing information for BARACLUDE. ®](https://www.pdfsearch.io/img/e87d3239e227d9a38bbbaa5952f8a3df.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-07-24 02:07:51
|
---|
10![PID comments (clarifax in January 2006) PID comments (clarifax in January 2006)](https://www.pdfsearch.io/img/c88262d2018f18685e86c6d13f223454.jpg) | Add to Reading ListSource URL: www.bmscanada.caLanguage: English - Date: 2013-12-10 10:20:22
|
---|